Previously, it was reported that EMX2OS predicted the recurrence-free survival of papillary thyroid cancer and correlated with the poor prognosis of kidney renal clear cell carcinoma [11,18]. This evidence concerns the gene EMX2OS and thyroid gland papillary carcinoma.